Report cover image

Oncology Sterile Injectables Market: Global Market Size, Forecast, Insights, and Competitive Landscape

Publisher Prodture
Published Oct 18, 2024
Length 140 Pages
SKU # PROD19315041

Description

Oncology Sterile Injectables Market: Global Market Size, Forecast, Insights, and Competitive Landscape


The global oncology sterile injectables market is expected to grow at a CAGR of around 3.4% during 2025-2034. This report on global oncology sterile injectables market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global oncology sterile injectables market by segmenting the market based on molecule type, product type, indication, branded/generics, distribution channel, application and region. Also, detailed profiles of companies operating in the oncology sterile injectables market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Faster Drug Approvals from Various Regulatory Bodies
• High Prevalence of Cancer
• Minimal Side Effects and Target-Oriented Attack

Market Challenges

• Stringent Rules and Regulations For Manufacturing
• Challenges in Storage, Packaging and Distribution

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Molecule Type

• Small Molecule
• Large Molecule

Market by Product Type

• Chemotherapy
Alkylating Agents
Antimetabolites
Plant Alkaloids
Antitumor Antibiotics
Others
• Monoclonal Antibodies
• Cytokines
• Peptide Hormones

Market by Indication

• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Stomach Cancer
• Others

Market by Branded/Generics

• Branded
• Generics

Market by Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

140 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Oncology Sterile Injectables Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Oncology Sterile Injectables Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Oncology Sterile Injectables Market by Molecule Type
5.1. Introduction
5.2. Small Molecule
5.3. Large Molecule
6. Global Oncology Sterile Injectables Market by Product Type
6.1. Introduction
6.2. Chemotherapy
6.2.1. Alkylating Agents
6.2.2. Antimetabolites
6.2.3. Plant Alkaloids
6.2.4. Antitumor Antibiotics
6.2.5. Others
6.3. Monoclonal Antibodies
6.4. Cytokines
6.5. Peptide Hormones
7. Global Oncology Sterile Injectables Market by Indication
7.1. Introduction
7.2. Lung Cancer
7.3. Breast Cancer
7.4. Colorectal Cancer
7.5. Prostate Cancer
7.6. Stomach Cancer
7.7. Others
8. Global Oncology Sterile Injectables Market by Branded/Generics
8.1. Introduction
8.2. Branded
8.3. Generics
9. Global Oncology Sterile Injectables Market by Distribution Channel
9.1. Introduction
9.2. Retail Pharmacies
9.3. Hospital Pharmacies
9.4. Online Pharmacies
10. Global Oncology Sterile Injectables Market by Region
10.1 Introduction
10.2 Europe
10.2.1 Germany
10.2.2 United Kingdom
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Russia
10.2.7 Netherlands
10.2.8 Rest of the Europe
10.3 North America
10.3.1 United States
10.3.2 Canada
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 Indonesia
10.4.7 Rest of the Asia Pacific
10.5 Latin America
10.5.1 Mexico
10.5.2 Brazil
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 Turkey
10.6.3 Iran
10.6.4 United Arab Emirates
10.6.5 Rest of Middle East & Africa
11. SWOT Analysis
12. Porter’s Five Forces
13. Market Value Chain Analysis
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Company Profiles
14.2.1. AstraZeneca
14.2.2. Baxter International Inc.
14.2.3. GILEAD SCIENCES, INC.
14.2.4. GlaxoSmithKline plc.
14.2.5. Johnson & Johnson Services, Inc.
14.2.6. Merck & Co., Inc.
14.2.7. Nova Nordisk A/S
14.2.8. Novartis AG
14.2.9. Pfizer Inc.
14.2.10. Sanofi
List of Figures
Figure 1: Global Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 2: Global Oncology Sterile Injectables Market by Molecule Type, 2024
Figure 3: Global Oncology Sterile Injectables Market by Product Type, 2024
Figure 4: Global Oncology Sterile Injectables Market by Indication, 2024
Figure 5: Global Oncology Sterile Injectables Market by Branded/Generics, 2024
Figure 6: Global Oncology Sterile Injectables Market by Distribution Channel, 2024
Figure 7: Global Oncology Sterile Injectables Market by Region, 2024
Figure 8: Global Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 9: Global Oncology Sterile Injectables Market by Molecule Type (in %), 2024 & 2034
Figure 10: Global Small Molecule Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 11: Global Small Molecule Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 12: Global Large Molecule Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 13: Global Large Molecule Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 14: Global Oncology Sterile Injectables Market by Product Type (in %), 2024 & 2034
Figure 15: Global Chemotherapy Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 16: Global Chemotherapy Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 17: Alkylating Agents Oncology Sterile Injectables Chemotherapy Market (in US$ Million), 2020-2034
Figure 18: Antimetabolites Oncology Sterile Injectables Chemotherapy Market (in US$ Million), 2020-2034
Figure 19: Plant Alkaloids Antimetabolites Oncology Sterile Injectables Chemotherapy Market (in US$ Million), 2020-2034
Figure 20: Antitumor Antibiotics Oncology Sterile Injectables Chemotherapy Market (in US$ Million), 2020-2034
Figure 21: Other Oncology Sterile Injectables Chemotherapy Market (in US$ Million), 2020-2034
Figure 22: Global Monoclonal Antibodies Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 23: Global Monoclonal Antibodies Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 24: Global Cytokines Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 25: Global Cytokines Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 26: Global Peptide Hormones Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 27: Global Peptide Hormones Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 28: Global Oncology Sterile Injectables Market by Indication (in %), 2024 & 2034
Figure 29: Global Lung Cancer Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 30: Global Lung Cancer Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 31: Global Breast Cancer Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 32: Global Breast Cancer Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 33: Global Colorectal Cancer Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 34: Global Colorectal Cancer Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 35: Global Prostate Cancer Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 36: Global Prostate Cancer Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 37: Global Stomach Cancer Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 38: Global Stomach Cancer Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 39: Global Other Indication Cancer Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 40: Global Other Indication Cancer Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 41: Global Oncology Sterile Injectables Market by Branded/Generics (in %), 2024 & 2034
Figure 42: Global Branded Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 43: Global Branded Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 44: Global Generics Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 45: Global Generics Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 46: Global Oncology Sterile Injectables Market by Distribution Channel (in %), 2024 & 2034
Figure 47: Global Retail Pharmacies Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 48: Global Retail Pharmacies Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 49: Global Hospital Pharmacies Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 50: Global Hospital Pharmacies Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 51: Global Online Pharmacies Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 52: Global Online Pharmacies Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 53: Global Oncology Sterile Injectables Market by Region (in %), 2024 & 2034
Figure 54: Europe Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 55: Europe Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 56: Europe Oncology Sterile Injectables Market by Country (in %), 2024 & 2034
Figure 57: Germany Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 58: United Kingdom Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 59: France Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 60: Italy Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 61: Spain Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 62: Russia Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 63: Netherlands Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 64: North America Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 65: North America Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 66: North America Oncology Sterile Injectables Market by Country (in %), 2024 & 2034
Figure 67: United States Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 68: Canada Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 69: Asia Pacific Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 70: Asia Pacific Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 71: Asia Pacific Oncology Sterile Injectables Market by Country (in %), 2024 & 2034
Figure 72: China Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 73: Japan Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 74: India Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 75: South Korea Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 76: Australia Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 77: Indonesia Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 78: Latin America Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 79: Latin America Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 80: Latin America Oncology Sterile Injectables Market by Country (in %), 2024 & 2034
Figure 81: Mexico Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 82: Brazil Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 83: Argentina Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 83: Middle East & Africa Oncology Sterile Injectables Market (in US$ Million), 2020-2024
Figure 84: Middle East & Africa Oncology Sterile Injectables Market (in US$ Million), 2025-2034
Figure 85: Middle East & Africa Oncology Sterile Injectables Market by Country (in %), 2024 & 2034
Figure 86: Saudi Arabia Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 87: Turkey Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 88: Iran Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 89: UAE Oncology Sterile Injectables Market (in US$ Million), 2020-2034
Figure 90: Market Value Chain
List of Tables
Table 1: Global Oncology Sterile Injectables Market Portraiture
Table 2: Global Oncology Sterile Injectables Market by Molecule Type (in US$ Million), 2024 & 2034
Table 3: Global Oncology Sterile Injectables Market by Product Type (in US$ Million), 2024 & 2034
Table 4: Chemotherapy Oncology Sterile Injectables Market by Product Type (in US$ Million), 2024 & 2034
Table 5: Global Oncology Sterile Injectables Market by Indication (in US$ Million), 2024 & 2034
Table 6: Global Oncology Sterile Injectables Market by Branded/Generics (in US$ Million), 2024 & 2034
Table 7: Global Oncology Sterile Injectables Market by Distribution Channel (in US$ Million), 2024 & 2034
Table 8: Global Oncology Sterile Injectables Market by Region (in US$ Million), 2024 & 2034
Table 9: Europe Oncology Sterile Injectables Market by Country (in US$ Million), 2024 & 2034
Table 10: North America Oncology Sterile Injectables Market by Country (in US$ Million), 2024 & 2034
Table 11: Asia Pacific Oncology Sterile Injectables Market by Country (in US$ Million), 2024 & 2034
Table 12: Latin America Oncology Sterile Injectables Market by Country (in US$ Million), 2024 & 2034
Table 13: Middle East & Africa Oncology Sterile Injectables Market by Country (in US$ Million),
2024 & 2034
Table 14: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us